US Stock MarketDetailed Quotes

CANF Can-Fite BioPharma

Watchlist

4.5000
+0.6000+15.38%

Close Jul 19 16:00 ET

4.5099
+0.0099+0.22%

Pre 08:00 ET

22.46MMarket Cap-1500P/E (TTM)

Can-Fite BioPharma Stock Forum

Trytosaveabit

Jun 28 06:16

$Can-Fite BioPharma(CANF.US)$ Can-fite Biopharma Says Its Veterinary Partner Vetbiolix Reported Positive Results In An Osteoarthritis Multicenter Clinical Study In Dogs Treated With Piclidenoson

Stock Region

Jun 25 18:00

Biotechnology Firm Reveals Breakthrough Discovery For Anti-cancer Treatment

Can-Fite BioPharma: New Findings Highlight Namodenoson's Mechanism in Liver Protection and Cancer Treatment.
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology firm dedicated to developing innovative treatments for oncological and inflammatory diseases, has unveiled new findings concerning its small molecule drug, Namodenoson. These recent discoveries shed light on the mechanisms by which Namodeno...

Trytosaveabit

May 9 07:25

News

$Can-Fite BioPharma(CANF.US)$ Benzinga· 2 mins ago
Rhe FDA Has Granted Investigational New Drug Clearance For Can-Fite Biopharma's Namodenoson, For Metabolic Dysfunction-Associated Steatohepatitis, Also Known As Non-alcoholic Steatohepatitis, For The Company's Ongoing Phase 2B Study

Jaguar8

May 6 06:28

$Can-Fite BioPharma(CANF.US)$
NEWS
Can-Fite Received Notice of Allowance from the European Patent Office for the Treatment of Erectile Dysfunction with CF602

Trytosaveabit

Feb 28 06:18

Update

$Can-Fite BioPharma(CANF.US)$ Can-Fite BioPharma Announced Notice Of Allowance In Canada For Its Patent Application Regarding Se Of Namodenoson For The Reduction Of Liver Fat In Patients With NASH

JESSE JAMES8832

Jan 29 06:10

Can-Fite: Top Scientific Journal Published Positive Data from the COMFORT-1 Phase III Psoriasis Study

$Can-Fite BioPharma(CANF.US)$

WillsPTW

Dec 18, 2023 07:05

👀

$Can-Fite BioPharma(CANF.US)$

Trytosaveabit

Dec 18, 2023 06:06

Update

$Can-Fite BioPharma(CANF.US)$ Can-Fite Receives Positive Response From FDA On Pediatric Study Plan For Treatment Of Children Suffering From Psoriasis With Piclidenoson
Moomoo 24/7· 1 min ago

Trytosaveabit

Dec 4, 2023 06:14

Update

$Can-Fite BioPharma(CANF.US)$ Can-Fite Biopharma Has Completed The Design Of Phase 2A Study Protocol For Pancreatic Cancer And Plans To Submit The Protocol Shortly To Ethical Committees For Approval, Study Will Aim To Enroll About 20 Patients To Establish Safety And Clinical Activity

Abela

Nov 21, 2023 13:17

$Can-Fite BioPharma(CANF.US)$ wow what happened

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

Concept

Top Gainers Yesterday

Intraday-1.47%